한국어
Quantus

Vera Therapeutics Class A

VERA · Nasdaq
$35.89+2.57%
2026-09-04 close

Vera Therapeutics Class A last closed at $35.89 (+2.57%) on 2026-09-04. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

C
Overall: 건강관리 550/745 · top 74%
Factor composite · relative position in sector

PER — · PBR 4.35 — own-history percentile 67/100 · 80/100

Open self-history band
PER67/100
PBR80/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 9.97
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
9.97
Beneish M-Score
—

Statistical flag unavailable

Sloan accrual
-2.66%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROAPass
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtPass
  • Higher current ratioPass
  • No new sharesPass

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Connections

AI-extracted related companies · for reference

Customers
Nephrology care providers
Competitors
Vertex PharmaceuticalsPrice comovement r=0.18 (1 year)Otsuka PharmaceuticalNovartisAstraZenecaTakeda Pharmaceutical
Same theme
Fresenius Medical CareDaVitaPrice comovement r=0.14 (1 year)CKD treatment market
🔗 See in the full market map →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About Vera Therapeutics Class A
What technical signals does Vera Therapeutics Class A (VERA) have?
Vera Therapeutics Class A current technical signals: no active technical signal.
Is Vera Therapeutics Class A a cup-and-handle pattern?
No. Vera Therapeutics Class A has no valid cup-and-handle signal right now.
What are Vera Therapeutics Class A's financials and valuation?
Vera Therapeutics Class A's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy